EndHep2030 Call for Proposals

EndHep2030 partners with innovative organizations to tackle the difficult, yet solvable, problems for reaching viral hepatitis elimination goals and preventing deaths associated with severe liver disease, including liver cancer.

EndHep2030 supports innovative approaches for accelerating the elimination of viral hepatitis with respect to one or both of the following tracks and specific challenges:

Track 1: Use of Data to Inform Planning and Financing

  • Harnessing the power of data to capture the attention of senior leaders and make the data easy to understand for key stakeholders so that they are moved to confront the burden of hepatitis.
  • Working with Ministry of Health and Ministry of Finance officials to develop a strategic approach to financing.

Track 2: Developing Programs to Deliver Services

  • Saving lives by promoting maternal, newborn, and child health.
  • Identifying approaches for accelerating the testing of populations for hepatitis to identify those persons who have chronic infection and linking them to appropriate care.

EndHep2030 does not accept unsolicited applications for funding, but rather selects organisations to support following careful research. 

Please send any questions about our grants to grants@endhep2030.org



Our 2020 grants were announced on World Hepatitis Day (28 July) 2020. As the projects progress we will be updating this page to demonstrate the progress and the impact of the grants. 


Geographical Scope

  Project Aim


Produce data analytics which will be used to inform policy formulation, national planning and implementation in Sub-Saharan Africa.

South-East Asia and Western Pacific

Develop and roll out an operational guide to assist countries in performing monitoring and evaluation in the WPRO and SEARO regions.


Expand public engagement in HBV/HCV and crowdsource to spur hepatitis policy

Western Pacific

Demonstrate an integrated viral hepatitis strategy to increase access to diagnostic and treatment services in major urban areas with high prevalence in East Asia.


Support a regional approach to hepatitis policy change in the Andean region.


Strengthen capacity for national hepatitis planning across the world.


Develop a monitoring and evaluation logframe for viral hepatitis catalytic funding.

Eastern Mediterranean

Demonstrate how to effectively increase hepatitis C screening and treatment by mobilizing rural health centres in high prevalence settings.


Support efforts to maintain the momentum for a global campaign to eliminate viral hepatitis.


Implement a decentralized and integrated strategy through a national capacity building training programme in Sub-Saharan Africa.